Investors dump Juno on clinical hold

Juno Therapeutics Inc. (NASDAQ:JUNO) fell 32% on Friday, as investors sold on late Thursday's news that FDA placed a clinical hold on

Read the full 227 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE